Objective: Central fat mass (CFM) correlates with insulin resistance and increases the risk of type 2 diabetes and cardiovascular complications. On the other hand, increased peripheral fat mass (PFM) is associated with higher insulin sensitivity. Thus, we examined the contribution of adipose tissue distribution, as assessed by the PFM/CFM ratio, to insulin sensitivity in overweight and obese postmenopausal women. Design and methods: A total of 124 nondiabetic overweight and obese postmenopausal women underwent an oral glucose tolerance test (OGTT) and a hyperinsulinemic/euglycemic (HI) clamp. Body composition was determined using computed tomography for visceral adipose tissue (VAT) and dual X-ray absorptiometry for fat mass, lean body mass and their respective proportions. Participants were divided by tertiles of the PFM/CFM ratio. Results: Participants with preferential CFM (group 1) had higher fasting insulin levels and insulin area under the curve (AUC) during OGTT, as well as lower glucose infusion rates during the HI clamp, whether it was expressed per kg of body weight (M) or per kg of fat-free mass (Mm), compared with the other two groups. The PFM/CFM ratio also correlated significantly with fasting insulin (r ¼ À0.32, Po0.001), the insulin AUC (r ¼ À0.42 Po0.001), M (r ¼ 0.39 Po0.001) and Mm (r ¼ 0.37 Po0.001). Using hierarchical regression, we demonstrated that the PFM/CFM ratio was an independent predictor of insulin AUC, M and Mm and that its sequential addition to CFM and VAT improved significantly the predictive value of the model for insulin sensitivity for all variables except fasting insulin. Conclusion: The PFM/CFM ratio, which integrates the antagonistic effects of both central and peripheral depots on insulin sensitivity, added substantially to the prediction of insulin sensitivity over VAT and CFM alone.
Introduction
Obesity is associated with metabolic complications such as insulin resistance, type 2 diabetes and hypertension. 1 However, we and others [2] [3] [4] [5] [6] have documented the presence of both insulin-resistant normal-weight participants and obese individuals who are insulin sensitive despite their obesity. These studies highlight the wide interindividual differences in insulin sensitivity that exists for any given amount of body fat, suggesting that additional factors modulate insulin action. Marked differences exist between various fat depots with respect to their contribution to insulin resistance and its associated cardiometabolic risk factors. Large epidemiological studies have highlighted the contribution of central fat to insulin resistance and to the increased risk of type 2 diabetes and cardiovascular diseases. [7] [8] [9] [10] [11] [12] Furthermore, low thigh fat is associated with higher fasting glucose, whereas high peripheral fat is linked to increased insulin sensitivity. [13] [14] [15] Thus, peripheral fat may be a protective factor counterbalancing the adverse effect of central fat on insulin sensitivity. Various methods have been developed to measure body fat distribution. Waist circumference is widely viewed as a simple and more specific measure than body mass index (BMI) for assessing obesity-related health risks. 16, 17 However, it does not take into account the potential beneficial contribution of peripheral fat mass (PFM) to the metabolic profile. Past studies have established the waist-to-hip ratio (WHR) as a valuable predictor of insulin resistance, cardiovascular disease and all-cause mortality. 12 However, hip circumference is influenced by both fat and lean masses from the legs, both of which can modulate insulin sensitivity and the metabolic profile differently. On the other hand, dual-energy X-ray absorptiometry provides a measure of lean body mass (LBM) and fat mass and their anatomic localization allowing for a better estimate of their contribution to insulin sensitivity. We hypothesized that the PFM/central fat mass (CFM) ratio would be a good predictor of insulin sensitivity. To test this hypothesis, we examined the contribution of regional fat distribution, as reflected by the PFM/CFM ratio, to insulin sensitivity in a population of overweight and obese postmenopausal women using gold standard methods to measure insulin sensitivity (hyperinsulinemic/euglycemic (HI) clamp) and body fat distribution (dual-energy X-ray absorptiometry and computed tomography (CT) scan)).
Methods

Participants
One hundred and thirty seven postmenopausal women, aged 45-70 years, who responded to our advertisement seeking 'healthy overweight and obese postmenopausal women for a weight loss study' in the Montreal area from May 2003 to February 2006, were recruited. Of these women, 13 were excluded because of missing data and, thus, our analyses included 124 participants. All participants gave informed written consent before participation in accordance with the ethical guidelines of the Université of Montréal Research Ethics Committee.
As described previously, 18, 19 women were included in the study if they met the following criteria: (1) cessation of menstruation for more than 1 year and a follicle-stimulating hormone level X30 U l À1 , (2) sedentary (o2 h a week of structured exercise), (3) non-smokers, (4) free of known inflammatory diseases, (5) no use of hormone replacement therapy and (6) BMI X27 kg/m 2 . On physical examination or biological testing, all participants had no history or evidence of cardiovascular diseases, peripheral vascular diseases or stroke, diabetes (fasting serum glucose o7.0 mmol l À1 and 2-h post 75 g oral glucose tolerance test (OGTT) o11.0 mmol l À1 ), orthopedic limitations, weight fluctuation in the past 3 months ( ± 2 kg), thyroid or pituitary diseases, infection (tested by medical questionnaire and complete blood count) and medication that could affect cardiovascular function and/or metabolism.
Study design
Participants were invited to the Université of Montréal Metabolic Unit at 0730 hours in the fasting state for the inclusion testing protocol (OGTT, fasting blood samples, physical examination). Participants who were included in the study went through a 4-week weight stabilization period (±2 kg), verified by weekly weighing at the research unit, after which they underwent an HI clamp. Body composition was assessed by dual-energy X-ray absorptiometry and CT scan within the next 2 weeks.
Fasting blood sample
After a 12-h overnight fast, venous blood samples were collected. Fasting glucose levels were measured immediately using the glucose oxidase method (glucose analyzerF Beckman Coulter, Fullerton, CA, USA), whereas insulin levels were quantified in duplicate by radioimmunoassay with human insulin serving as standard (Linco Research, St-Charles, MO, USA).
Oral glucose tolerance test A 2-h 75 g OGTT was performed in the morning after a 12-h fast, according to the guidelines of the American Diabetes Association. 20 Blood samples were collected at 0, 30, 60, 90
and 120 min and both plasma glucose and insulin levels were measured. The area under the curve (AUC) for insulin and glucose was determined with Graph Pad Prism (Version 3.0, San Diego, CA, USA).
HI clamp
The clamp began at 0730 hours after a 12-h overnight fast according to the procedure described previously by DeFronzo et al. 21 Three basal blood samples were taken over 40 min, after which insulin was infused at a prime constant rate of 75 mU m À2 min À1 for 180 min. Plasma glucose was measured every 5-10 min with a glucose analyzer and maintained at the fasting level with variable infusion rates of 20% dextrose. Two insulin-sensitivity indices were computed by HI clamp: M, which is the glucose infusion rate by kg body weight (mg min À1 kg À1 ), and Mm, which is the glucose infusion rate by kg of fat-free mass (FFM) (mg per min per kg of FFM). )). Waist and hip circumferences were measured with a non-extendable linear tape measure. Dual-energy X-ray absorptiometry was used to measure regional and whole-body composition (version 6.10.019, General Electric Lunar Corporation, Madison, WI, USA). The central body region was defined by the following boundaries: a horizontal line below the chin, two vertical lines passing through the arm sockets along the edges of the rib (separating the arms from the body) and two diagonal lines beginning on the side of the trunk on top of the pelvis bone and meeting at the end of the soft tissue between the legs. The amount of peripheral fat tissue was determined by adding the quantity of fat present in the arms and the legs outside these boundaries. The same strategy was used to determine peripheral and central lean body masses.
Body composition
Computed tomography
A GE high-speed Advantage CT scanner (General Electric Medical Systems, Milwaukee, WI, USA) was used to measure visceral adipose tissue (VAT). The participants were examined in the supine position with both arms stretched above their head. The position of the scan was established at the L4/L5 level according to a scout image of the body. VAT area was quantified by delineating the intra-abdominal cavity at the most internal aspect of the abdominal and oblique muscle wall surrounding the cavity and the posterior aspect of the vertebral body. Cross-sectional areas of adipose tissue were highlighted and computed by attenuation ranging from À190 to À30 Hounsfield units, using commercially available software (GE Medical Systems).
Statistical analysis
Data are presented as mean ± standard deviation (s.d.). Both fasting insulin and the insulin AUC failed the Levene's homogeneity test of variance and were log-transformed for analysis. We first stratified the cohort in tertiles of PFM/CFM. The three groups were then compared by one-way ANOVA followed by Tukey's HSD post hoc test. Associations between the PFM/CFM ratio and markers of insulin sensitivity (fasting insulin, insulin AUC, M, Mm) were examined by Pearson correlation. We then used a hierarchical regression to examine the contribution of PFM/CFM to insulin sensitivity. The following variables were significantly associated with insulin sensitivity and were included in the model: age, body weight, BMI, total fat mass, LBM, peripheral lean mass, central lean mass, VAT. However, for M and Mm, body weight and LBM were excluded, respectively, as they were taken into account in the calculation of those two variables. We then added the PFM/CFM ratio to the model. This sequential process of hierarchical regression allowed us to determine the change in explained variance after the addition of the ratio and thus its contribution to insulin sensitivity. Because some of these variables are known to be correlated, their collinearity in the regression model was also assessed. We found that collinearity between the variables did not influence the results. We used SPSS for Windows (Version 13.0 SPSS, Chicago, IL, USA) for statistical analysis. Significance was accepted at Po0.05.
Results
At inclusion, all participants had a BMI over 27 kg/m 2 . On the test day, five participants displayed a BMI below 27 kg/m 2 related to slight weight loss during the stabilization period. These participants were included in the analysis on the basis of their weight at the inclusion visit. Participants were stratified in tertiles of PFM/CFM. As shown in Table 1 , the three groups were similar for age as well as percentage of body fat. However, women with the lowest PFM/CFM ratio, that is, with preferential android obesity (group 1), displayed higher body weight, BMI, waist circumference, total body Table 1 Anthropometric characteristic of the study subjects Fat distribution modulates insulin sensitivity B Tousignant et al fat, VAT mass, CFM as well as total and central lean body mass compared with group 2 or 3 (Po0.05). In addition, group 3 also showed significantly higher PFM and lower WHR than group 1 (Po0.05). Among the participants, 6.3% had impaired fasting glucose and 20.6% impaired glucose tolerance (Table 2) and there was no statistical difference in the prevalence of either impaired fasting glucose or impaired glucose tolerance between the three groups (data not shown).
As seen in Figure 1a , women with the lowest PFM/CFM ratio displayed 34% (Po0.001) and 46% (Po0.001) increases in fasting plasma insulin levels compared with groups 2 and 3, respectively. Group 1 also showed a 74% increase in insulin AUC compared with groups 2 and 3 (Po0.001, for both groups; Figure 1b ). These differences were reflected during the HI clamp where group 1 showed a reduced glucose infusion rate compared with the other two groups, whether it was expressed per unit of body weight (M) (17 and 22% decreased compared with groups 2 and 3; Po0.001) or per unit of FFM (Mm) (15 and 20% lower than in groups 2 and 3; P ¼ 0.001). On the other hand, there was no significant difference for any of these parameters between groups 2 and 3. During the clamp, insulin steady-state concentrations were 211 ± 37, 195 ± 32 and 196 ± 32 mU ml À1 for groups 1, 2 and 3, respectively, and these differences did not reach statistical significance (P40.05). Thus, individuals with preferential android distribution (group 1) displayed higher insulin levels, elevated insulin AUC during the OGTT and a lower glucose infusion rate (M and Mm) during the HI clamp compared with the other two groups.
We next examined the association between the PFM/CFM ratio and various insulin sensitivity indices using Pearson correlation. The ratio correlated with fasting insulin levels (r ¼ À0.32; Po0.01), insulin AUC (r ¼ À0.42; Po0.01), M (r ¼ 0.39; Po0.01) and Mm (r ¼ 0.37; Po0.01). Similar correlation coefficients were observed after controlling for age (data not shown). To better understand the relationship between the PFM/CFM ratio and insulin sensitivity, we also evaluated the individual associations of VAT, CFM and PFM with insulin sensitivity indices. VAT correlated positively fat, all the analyses were adjusted for this variable to evaluate the independent contribution of each fat depot to insulin-sensitivity indices. As shown in Table 3 , correcting for total fat mass did not change significantly the association between either VAT or CFM and insulin-sensitivity indices. Furthermore, after controlling for total body fat, there was a trend for PFM to correlate with fasting insulin levels (r ¼ À0.17; P ¼ 0.057). In addition, PFM correlated negatively with insulin AUC (r ¼ À0.28; Po0.001) and positively with M (r ¼ 0.24; Po0.01) and Mm (r ¼ 0.24; Po0.01).
Because fat distribution is usually evaluated by anthropometric measures, we also examined the association between the PFM/CFM ratio and waist circumference and WHR. Both waist (r ¼ À0.48; Po0.001) and WHR (r ¼ À0.51; Po0.001) exhibited significant correlation with the ratio.
We next determined the contribution of the PFM/CFM ratio to insulin sensitivity in our cohort using a hierarchical regression. The following variables were independent predictors of fasting insulin (VAT and LBM), insulin AUC (VAT), M (VAT and CFM) and Mm (CFM) and were thus included in the model first so that the independent contribution of the PFM/CFM ratio could be determined. As shown in Table 4 , for fasting insulin level, the sequential addition of the PFM/CFM ratio did not improve the predictive value of our model. On the other hand, inclusion of the ratio in the model induced a significant incremental increase in R 2 for insulin AUC (Po0.001), M (P ¼ 0.006) and Mm (Po0.001). Thus, addition of the PFM/CFM ratio to the models improved substantially their predictive value for all insulin sensitivity indices except for fasting insulin.
Discussion
Obesity is a major risk factor for type 2 diabetes mellitus 22 as well as for a cluster of cardiovascular risk factors associated with insulin resistance. 23, 24 Studies have shown that android fat distribution has a better prognostic value than BMI for both the risk of diabetes and cardiac events. [7] [8] [9] [10] [11] [12] 25 Furthermore, recent evidence indicates that PFM could provide some degree of protection against metabolic complications. [25] [26] [27] [28] [29] On the basis of this information, we hypothesized that the PFM/CFM ratio, which integrates the effects of both fat depots, would be an important predictor of insulin resistance. This study demonstrated that women who presented a higher PFM/CFM ratio (that is, preferential gynoid fat distribution) had lower fasting insulin levels, reduced insulin AUC during the OGTT as well as increased insulin sensitivity, as measured by the HI clamp, compared with women who had android obesity. Furthermore, our analysis revealed that inclusion of the ratio in the model substantially improved its predictive value beyond CFM and VAT alone. Our results demonstrated that the PFM/CFM ratio was associated with various measures of insulin sensitivity. These associations were reflected in individual components of the ratio, and as reported previously, CFM and VAT were associated with deteriorated insulin sensitivity, whereas increased PMF seems to have a beneficial effect on this parameter. 30 We also observed similar associations between the PFM/CFM ratio and both the waist circumference and the WHR. However, and as shown in Table 1 , the WHR did not parallel the PFM/CFM ratio across tertiles. Thus, despite important difference in insulin sensitivity, groups 1 and 2 presented similar WHR values. On the other hand, groups 2 and 3 had similar insulin sensitivity indices and displayed similar waist circumferences, suggesting that this parameter may better reflect insulin sensitivity. Previous studies have demonstrated that the hip circumference is strongly associated with both fat mass and lean mass of the legs 27 and this may affect the correlation between PFM/CFM and the WHR. Our results demonstrated that the PFM/CFM ratio was a predictor of insulin sensitivity but not of fasting insulin levels. We may hypothesize that fasting measurements may Investigation of metabolically obese normal-weight and lipodystrophic participants showed that even in individuals with low total fat, alteration of the ratio was associated with deteriorated insulin sensitivity. 4, 32 In type 2 diabetics, thiazolidinedione improved glucose control despite significant weight gain. 33 Importantly, fat incretion occurred mostly in peripheral subcutaneous adipose tissue, often in the absence of any changes in visceral mass, resulting in a more favorable PFM/CFM ratio. [34] [35] [36] [37] Redistribution of fat mass from peripheral locations to abdominal depots following a carbohydrate-enriched diet also led to diminished insulin sensitivity. 38 Together, these studies suggest that a higher PFM/CFM ratio may be an important contributor to preserved insulin sensitivity. Several mechanisms may contribute to the beneficial effect of peripheral adipose tissue on insulin sensitivity. 39, 40 Peripheral adipocytes are less lipolytic than their visceral counterpart. 39, 40 Furthermore, they trap fatty acids very efficiently 1 and this may lead to faster storage of postprandial lipids, which would minimize the risk of ectopic fat deposition and consequently lipotoxicity. 41 In addition, peripheral adipose tissue expressed lower levels of inflammatory proteins, including 11-b-hydroxysteroid dehydrogenase-1, interleukin-6 and plasminogen activator inhibitor-1, compared with abdominal adipose tissue, and this may contribute to the protective effect of peripheral fat on insulin sensitivity. 42, 43 Although the lowest tertile of PFM/CFM is associated with lower insulin sensitivity, we did not observe any significant differences between the other two groups, indicating that a threshold may exist. It may be that once the buffering capacity is reached, further increments of PFM do not improve the metabolic profile. It has recently been proposed that when peripheral adipocytes reach their storage limit for fatty acids, they lose their protective benefits. 34 A reduction in the ability of peripheral fat to trap fatty acids may then cause redistribution toward central fat and/or favor ectopic fat deposition in tissues such as muscle leading to insulin resistance. 44 This study has limitations. First, our cohort is composed only of overweight and obese nondiabetic sedentary postmenopausal women, and thus our findings are limited to this population. Secondly, our cross-sectional approach does not allow us to draw conclusions on any causal associations. Despite these limitations, our results are strengthened by the use of gold standard techniques in a relatively large, well-characterized cohort.
In conclusion, women with the lowest PFM/CFM ratio displayed reduced insulin sensitivity compared with women with preferential peripheral fat accumulation. Furthermore, the PFM/CFM ratio is an important predictor of insulin sensitivity. Thus, this ratio may integrate the antagonistic effect of PFM and CFM on insulin sensitivity and contribute to the wide intervariation observed for insulin sensitivity even within an apparently homogeneous population.
